Venous Thromboembolism Risk Assessment and Thromboprophylaxis Practice in General Medical Patients Requiring Admissions to General Wards: A Singapore's Perspective, Part 2

We have previously conducted a survey[1] on specialist physicians (associate consultants, consultants, and senior consultants) who are in charge of general medical admissions in general wards of three public hospitals in Singapore in September 2020. It showed only 47 and 23% of the respondents perform venous thromboembolism (VTE) risk assessment and prescribe VTE prophylaxis, respectively, in general medical patients admitted to general wards despite VTE prophylaxis is recommended by major international guidelines.[2] [3] [4]

As the incidence of VTE is on the rise in Singapore,[5] we wonder if the nonspecialist physicians, who are generally younger, have different perception about VTE risk assessment and thromboprophylaxis in comparison to the more senior specialist physicians. We therefore conducted a similar survey on nonspecialist physicians of the same three public hospitals.

Publication History

Article published online:
31 August 2021

• References

• 1 Chaozer ER, Kuthiah N, Adamjee T, Tay JC. Venous Thromboembolism Risk Assessment and Thromboprophylaxis Practice in General Medical Patients Requiring Admissions to General Wards: A Singapore's Perspective. Int J Angiol 2021; DOI: 10.1055/s-0041-1727135. . Accessed on May 18, 2021
• 2 Kahn SR, Lim W, Dunn AS. et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 suppl): e195S-e226S
• 3 National Institute for Health and Care Excellence. Venous thromboembolism in over 16s; reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. Accessed April 27, 2021 at: www.nice.org.uk/guidance/ng89
• 4 Schünemann HJ, Cushman M, Burnett AE. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2018; 2 (22) 3198-3225
• 5 Ng HJ, Lee LH. Trends in prevalence of deep venous thrombosis among hospitalised patients in an Asian institution. Thromb Haemost 2009; 101 (06) 1095-1099
• 6 Barbar S, Noventa F, Rossetto V. et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8 (11) 2450-2457
• 7 Lloyd NS, Douketis JD, Moinuddin I, Lim W, Crowther MA. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. J Thromb Haemost 2008; 6 (03) 405-414
• 8 Chao T-F, Chen S-A. Stroke and bleeding risk in Asians with atrial fibrillation. American College of Cardiology; 2016. https://www.acc.org/latest-in-cardiology/articles/2016/03/14/07/27/stroke-and-bleeding-risk-in-asians-with-atrial-fibrillation
• 9 Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost 2017; 117 (12) 2243-2260